{"id":"W2161317196","doi":"10.1093/annonc/mdq599","title":"A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors","year":2010,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Pharmacology; Toxicity; Phases of clinical research; Internal medicine; Oncology; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001134724,0.001034031,0.002219057,0.0003421101,0.0003983591,0.0009017234,0.0007188997,0.0009611062,0.003620189],"category_scores_gemma":[0.001115972,0.0006795135,0.001174635,0.0003996497,0.0007660252,0.0007852868,0.0002908125,0.003606782,0.0008009932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009468672,"about_ca_system_score_gemma":0.001747856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008436827,"about_ca_topic_score_gemma":0.002105118,"domain_scores_codex":[0.9995754,0.0001874799,0.00001704537,0.00007795353,0.00004569986,0.0000962816],"domain_scores_gemma":[0.9992743,0.0001395513,0.0001387001,0.00006293226,0.00003930988,0.0003451972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6831389,0.06278766,0.01063323,0.0008844567,0.002164597,0.0004286913,0.000349424,0.003754622,0.1124934,0.0007671288,0.006595181,0.1160027],"study_design_scores_gemma":[0.4812213,0.4858671,0.0166586,0.00002989879,0.0008739874,0.0007108707,0.00007604164,0.002027625,0.006624726,0.0004064351,0.005446709,0.00005680339],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918385,0.001900674,0.001051342,0.0004747603,0.0001472532,0.001103742,0.00089432,0.0001196707,0.002469671],"genre_scores_gemma":[0.989555,0.001380199,0.001945191,0.0008390826,0.0001875329,0.001451704,0.001648102,0.00005396565,0.002939142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003620189,"threshold_uncertainty_score":0.01211071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04438455420959794,"score_gpt":0.3921113069598411,"score_spread":0.3477267527502432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}